DreamCIS, Inc. (KOSDAQ:223250)

DreamCIS Revenue

DreamCIS had revenue of 20.01B KRW in the quarter ending June 30, 2026, with 20.54% growth. This brings the company's total for the last twelve months to 73.28B, up 14.96% year-over-year. In the year 2025, DreamCIS had annual revenue of 66.63B with 13.60% growth. That makes DreamCIS the 27,199th largest company in the world by revenue and 1,646th in South Korea.

• Revenue (ttm): 73.28B
• Revenue Growth: +14.96%
• P/S Ratio: 1.40
• Revenue / Employee: 187.42M
• Employees: 411
• Market Cap: 102.46B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Clinical Trial Management Agency 49.35B 70.1%
• Medical Consulting 15.43B 21.9%
• Clinical Trial Human Resources Support Department 5.66B 8.0%

By Geography

Chart

• South Korea 62.13B 93.2%
• Overseas 4.50B 6.8%

Fiscal year ended Dec 31, 2025 See the full DreamCIS breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	66.63B	7.98B	13.60%
Dec 31, 2024	58.65B	10.81B	22.59%
Dec 31, 2023	47.84B	8.97B	23.08%
Dec 31, 2022	38.87B	12.72B	48.64%
Dec 31, 2021	26.15B	2.66B	11.34%

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error